Palatin Technologies
PTN
#10934
Rank
โ‚ฌ8.35 M
Marketcap
4,69ย โ‚ฌ
Share price
-4.10%
Change (1 day)
-59.92%
Change (1 year)

Earnings for Palatin Technologies (PTN)

Earnings in 2026 (TTM): -โ‚ฌ7.25 Million

According to Palatin Technologies's latest financial reports the company's current earnings are โ‚ฌ13.18 Million. In 2025 the company made an earning of -โ‚ฌ8.77 Million, an increase over its 2024 earnings that were of -โ‚ฌ24.55 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Palatin Technologies from 1998 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚ฌ7.25 Million-17.31%
2025 -โ‚ฌ8.77 Million-64.29%
2024 -โ‚ฌ24.55 Million-16.9%
2023 -โ‚ฌ29.55 Million5.99%
2022 -โ‚ฌ27.88 Million-13.7%
2021 -โ‚ฌ32.3 Million33.25%
2020 -โ‚ฌ24.24 Million-172.11%
2019 โ‚ฌ33.61 M2352.33%
2018 โ‚ฌ1.37 M-94.13%
2017 โ‚ฌ23.35 M-154.92%
2016 -โ‚ฌ42.53 Million3.67%
2015 -โ‚ฌ41.02 Million878%
2014 -โ‚ฌ4.2 Million-72.64%
2013 -โ‚ฌ15.33 Million-33.11%
2012 -โ‚ฌ22.92 Million77.71%
2011 -โ‚ฌ12.9 Million
2003 -โ‚ฌ21.84 Million29.93%
2002 -โ‚ฌ16.81 Million36.18%
2001 -โ‚ฌ12.35 Million
1999 -โ‚ฌ10.25 Million6.04%
1998 -โ‚ฌ9.66 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ17.06 B-223,736.60%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚ฌ13.75 B-180,349.59%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
โ‚ฌ0.78 B-10,409.19%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
-โ‚ฌ9.8 Million 28.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
โ‚ฌ55.5 M-827.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-โ‚ฌ0.11 Billion 1,305.44%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
โ‚ฌ0.14 B-1,985.50%๐Ÿ‡บ๐Ÿ‡ธ USA
GlycoMimetics
GLYC
-โ‚ฌ26.88 Million 252.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
-โ‚ฌ50.36 Million 560.06%๐Ÿ‡บ๐Ÿ‡ธ USA